May 13, 2013 | According to researchers at Total Care Cancer (a comprehensive approach to cancer launched at Moffitt Cancer Center), using biosamples for phase II cancer trials improves research efficiency, cost, and the rate of drug development. Using a patient’s biological and molecular profile, researchers at Total Care Cancer can identify potential candidates for clinical trials. This study was published March 15 in Statistical Methods in Medical Research. News Medical